img

Global Antivenin Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antivenin Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Antivenin is a medication made from antibodies which is used to treat certain venomous bites and stings. They are recommended only if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
Antivenin report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antivenin market is projected to reach US$ 1277.8 million in 2034, increasing from US$ 959.2 million in 2022, with the CAGR of 4.1% during the period of 2024 to 2034. Demand from Hospitals and Clinics and Non-profit Institutions are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Antivenin industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Antivenin key manufacturers include CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts and Bharat Serums and Vaccines, etc. CSL, Merck, BTG are top 3 players and held % sales share in total in 2022.
Antivenin can be divided into Polyvalent and Monovalent, etc. Polyvalent is the mainstream product in the market, accounting for % sales share globally in 2022.
Antivenin is widely used in various fields, such as Hospitals and Clinics and Non-profit Institutions, etc. Hospitals and Clinics provides greatest supports to the Antivenin industry development. In 2022, global % sales of Antivenin went into Hospitals and Clinics filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antivenin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
CSL
Segment by Type
Polyvalent
Monovalent

Segment by Application


Hospitals and Clinics
Non-profit Institutions

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antivenin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antivenin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antivenin industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Antivenin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antivenin introduction, etc. Antivenin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Antivenin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Antivenin Market Overview
1.1 Antivenin Product Overview
1.2 Antivenin Market Segment by Type
1.2.1 Polyvalent
1.2.2 Monovalent
1.3 Global Antivenin Market Size by Type
1.3.1 Global Antivenin Market Size Overview by Type (2024-2034)
1.3.2 Global Antivenin Historic Market Size Review by Type (2024-2024)
1.3.3 Global Antivenin Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antivenin Sales Breakdown by Type (2024-2024)
1.4.2 Europe Antivenin Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Antivenin Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Antivenin Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Antivenin Sales Breakdown by Type (2024-2024)
2 Global Antivenin Market Competition by Company
2.1 Global Top Players by Antivenin Sales (2024-2024)
2.2 Global Top Players by Antivenin Revenue (2024-2024)
2.3 Global Top Players by Antivenin Price (2024-2024)
2.4 Global Top Manufacturers Antivenin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antivenin Market Competitive Situation and Trends
2.5.1 Antivenin Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Antivenin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antivenin as of 2022)
2.7 Date of Key Manufacturers Enter into Antivenin Market
2.8 Key Manufacturers Antivenin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antivenin Status and Outlook by Region
3.1 Global Antivenin Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Antivenin Historic Market Size by Region
3.2.1 Global Antivenin Sales in Volume by Region (2024-2024)
3.2.2 Global Antivenin Sales in Value by Region (2024-2024)
3.2.3 Global Antivenin Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Antivenin Forecasted Market Size by Region
3.3.1 Global Antivenin Sales in Volume by Region (2024-2034)
3.3.2 Global Antivenin Sales in Value by Region (2024-2034)
3.3.3 Global Antivenin Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Antivenin by Application
4.1 Antivenin Market Segment by Application
4.1.1 Hospitals and Clinics
4.1.2 Non-profit Institutions
4.2 Global Antivenin Market Size by Application
4.2.1 Global Antivenin Market Size Overview by Application (2024-2034)
4.2.2 Global Antivenin Historic Market Size Review by Application (2024-2024)
4.2.3 Global Antivenin Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antivenin Sales Breakdown by Application (2024-2024)
4.3.2 Europe Antivenin Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Antivenin Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Antivenin Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Antivenin Sales Breakdown by Application (2024-2024)
5 North America Antivenin by Country
5.1 North America Antivenin Historic Market Size by Country
5.1.1 North America Antivenin Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Antivenin Sales in Volume by Country (2024-2024)
5.1.3 North America Antivenin Sales in Value by Country (2024-2024)
5.2 North America Antivenin Forecasted Market Size by Country
5.2.1 North America Antivenin Sales in Volume by Country (2024-2034)
5.2.2 North America Antivenin Sales in Value by Country (2024-2034)
6 Europe Antivenin by Country
6.1 Europe Antivenin Historic Market Size by Country
6.1.1 Europe Antivenin Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Antivenin Sales in Volume by Country (2024-2024)
6.1.3 Europe Antivenin Sales in Value by Country (2024-2024)
6.2 Europe Antivenin Forecasted Market Size by Country
6.2.1 Europe Antivenin Sales in Volume by Country (2024-2034)
6.2.2 Europe Antivenin Sales in Value by Country (2024-2034)
7 Asia-Pacific Antivenin by Region
7.1 Asia-Pacific Antivenin Historic Market Size by Region
7.1.1 Asia-Pacific Antivenin Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Antivenin Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Antivenin Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Antivenin Forecasted Market Size by Region
7.2.1 Asia-Pacific Antivenin Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Antivenin Sales in Value by Region (2024-2034)
8 Latin America Antivenin by Country
8.1 Latin America Antivenin Historic Market Size by Country
8.1.1 Latin America Antivenin Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Antivenin Sales in Volume by Country (2024-2024)
8.1.3 Latin America Antivenin Sales in Value by Country (2024-2024)
8.2 Latin America Antivenin Forecasted Market Size by Country
8.2.1 Latin America Antivenin Sales in Volume by Country (2024-2034)
8.2.2 Latin America Antivenin Sales in Value by Country (2024-2034)
9 Middle East and Africa Antivenin by Country
9.1 Middle East and Africa Antivenin Historic Market Size by Country
9.1.1 Middle East and Africa Antivenin Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Antivenin Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Antivenin Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Antivenin Forecasted Market Size by Country
9.2.1 Middle East and Africa Antivenin Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Antivenin Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 CSL
10.1.1 CSL Company Information
10.1.2 CSL Introduction and Business Overview
10.1.3 CSL Antivenin Sales, Revenue and Gross Margin (2024-2024)
10.1.4 CSL Antivenin Products Offered
10.1.5 CSL Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Antivenin Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Merck Antivenin Products Offered
10.2.5 Merck Recent Development
10.3 BTG
10.3.1 BTG Company Information
10.3.2 BTG Introduction and Business Overview
10.3.3 BTG Antivenin Sales, Revenue and Gross Margin (2024-2024)
10.3.4 BTG Antivenin Products Offered
10.3.5 BTG Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Antivenin Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Pfizer Antivenin Products Offered
10.4.5 Pfizer Recent Development
10.5 Haffkine Bio-Pharmaceutical
10.5.1 Haffkine Bio-Pharmaceutical Company Information
10.5.2 Haffkine Bio-Pharmaceutical Introduction and Business Overview
10.5.3 Haffkine Bio-Pharmaceutical Antivenin Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Haffkine Bio-Pharmaceutical Antivenin Products Offered
10.5.5 Haffkine Bio-Pharmaceutical Recent Development
10.6 Rare Disease Therapeutics
10.6.1 Rare Disease Therapeutics Company Information
10.6.2 Rare Disease Therapeutics Introduction and Business Overview
10.6.3 Rare Disease Therapeutics Antivenin Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Rare Disease Therapeutics Antivenin Products Offered
10.6.5 Rare Disease Therapeutics Recent Development
10.7 Flynn Pharma
10.7.1 Flynn Pharma Company Information
10.7.2 Flynn Pharma Introduction and Business Overview
10.7.3 Flynn Pharma Antivenin Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Flynn Pharma Antivenin Products Offered
10.7.5 Flynn Pharma Recent Development
10.8 Vins Bioproducts
10.8.1 Vins Bioproducts Company Information
10.8.2 Vins Bioproducts Introduction and Business Overview
10.8.3 Vins Bioproducts Antivenin Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Vins Bioproducts Antivenin Products Offered
10.8.5 Vins Bioproducts Recent Development
10.9 Bharat Serums and Vaccines
10.9.1 Bharat Serums and Vaccines Company Information
10.9.2 Bharat Serums and Vaccines Introduction and Business Overview
10.9.3 Bharat Serums and Vaccines Antivenin Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Bharat Serums and Vaccines Antivenin Products Offered
10.9.5 Bharat Serums and Vaccines Recent Development
10.10 Serum Biotech
10.10.1 Serum Biotech Company Information
10.10.2 Serum Biotech Introduction and Business Overview
10.10.3 Serum Biotech Antivenin Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Serum Biotech Antivenin Products Offered
10.10.5 Serum Biotech Recent Development
10.11 MicroPharm
10.11.1 MicroPharm Company Information
10.11.2 MicroPharm Introduction and Business Overview
10.11.3 MicroPharm Antivenin Sales, Revenue and Gross Margin (2024-2024)
10.11.4 MicroPharm Antivenin Products Offered
10.11.5 MicroPharm Recent Development
10.12 CSL
10.12.1 CSL Company Information
10.12.2 CSL Introduction and Business Overview
10.12.3 CSL Antivenin Sales, Revenue and Gross Margin (2024-2024)
10.12.4 CSL Antivenin Products Offered
10.12.5 CSL Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antivenin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antivenin Industrial Chain Analysis
11.4 Antivenin Market Dynamics
11.4.1 Antivenin Industry Trends
11.4.2 Antivenin Market Drivers
11.4.3 Antivenin Market Challenges
11.4.4 Antivenin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antivenin Distributors
12.3 Antivenin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Polyvalent
Table 2. Major Company of Monovalent
Table 3. Global Antivenin Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Antivenin Sales by Type (2024-2024) & (K Vials)
Table 5. Global Antivenin Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Antivenin Sales by Type (2024-2024) & (US& Million)
Table 7. Global Antivenin Market Share in Value by Type (2024-2024)
Table 8. Global Antivenin Price by Type (2024-2024) & (USD/Vial)
Table 9. Global Antivenin Sales by Type (2024-2034) & (K Vials)
Table 10. Global Antivenin Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Antivenin Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Antivenin Sales Market Share in Value by Type (2024-2034)
Table 13. Global Antivenin Price by Type (2024-2034) & (USD/Vial)
Table 14. North America Antivenin Sales by Type (2024-2024) & (K Vials)
Table 15. North America Antivenin Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Antivenin Sales (K Vials) by Type (2024-2024)
Table 17. Europe Antivenin Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Antivenin Sales (K Vials) by Type (2024-2024)
Table 19. Asia-Pacific Antivenin Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Antivenin Sales (K Vials) by Type (2024-2024)
Table 21. Latin America Antivenin Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Antivenin Sales (K Vials) by Type (2024-2024)
Table 23. Middle East and Africa Antivenin Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Antivenin Sales by Company (2024-2024) & (K Vials)
Table 25. Global Antivenin Sales Share by Company (2024-2024)
Table 26. Global Antivenin Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Antivenin Revenue Share by Company (2024-2024)
Table 28. Global Market Antivenin Price by Company (2024-2024) & (USD/Vial)
Table 29. Global Antivenin Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Antivenin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antivenin as of 2022)
Table 32. Date of Key Manufacturers Enter into Antivenin Market
Table 33. Key Manufacturers Antivenin Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Antivenin Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Antivenin Sales by Region (2024-2024) & (K Vials)
Table 37. Global Antivenin Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Antivenin Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Antivenin Sales Market Share in Value by Region (2024-2024)
Table 40. Global Antivenin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2024-2024)
Table 41. Global Antivenin Sales by Region (2024-2034) & (K Vials)
Table 42. Global Antivenin Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Antivenin Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Antivenin Sales Market Share in Value by Region (2024-2034)
Table 45. Global Antivenin Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2024-2034)
Table 46. Global Antivenin Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Antivenin Sales by Application (2024-2024) & (K Vials)
Table 48. Global Antivenin Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Antivenin Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Antivenin Sales Market Share in Value by Application (2024-2024)
Table 51. Global Antivenin Price by Application (2024-2024) & (USD/Vial)
Table 52. Global Antivenin Sales by Application (2024-2034) & (K Vials)
Table 53. Global Antivenin Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Antivenin Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Antivenin Sales Market Share in Value by Application (2024-2034)
Table 56. Global Antivenin Price by Application (2024-2034) & (USD/Vial)
Table 57. North America Antivenin Sales by Application (2024-2024) (K Vials)
Table 58. North America Antivenin Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Antivenin Sales by Application (2024-2024) (K Vials)
Table 60. Europe Antivenin Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Antivenin Sales by Application (2024-2024) (K Vials)
Table 62. Asia-Pacific Antivenin Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Antivenin Sales by Application (2024-2024) (K Vials)
Table 64. Latin America Antivenin Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Antivenin Sales by Application (2024-2024) (K Vials)
Table 66. Middle East and Africa Antivenin Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Antivenin Sales by Country (2024-2024) & (K Vials)
Table 68. North America Antivenin Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Antivenin Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Antivenin Sales Market Share in Value by Country (2024-2024)
Table 71. North America Antivenin Sales by Country (2024-2034) & (K Vials)
Table 72. North America Antivenin Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Antivenin Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Antivenin Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Antivenin Sales by Country (2024-2024) & (K Vials)
Table 76. Europe Antivenin Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Antivenin Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Antivenin Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Antivenin Sales by Country (2024-2034) & (K Vials)
Table 80. Europe Antivenin Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Antivenin Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Antivenin Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Antivenin Sales by Region (2024-2024) & (K Vials)
Table 84. Asia-Pacific Antivenin Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Antivenin Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Antivenin Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Antivenin Sales by Region (2024-2034) & (K Vials)
Table 88. Asia-Pacific Antivenin Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Antivenin Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Antivenin Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Antivenin Sales by Country (2024-2024) & (K Vials)
Table 92. Latin America Antivenin Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Antivenin Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Antivenin Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Antivenin Sales by Country (2024-2034) & (K Vials)
Table 96. Latin America Antivenin Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Antivenin Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Antivenin Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Antivenin Sales by Country (2024-2024) & (K Vials)
Table 100. Middle East and Africa Antivenin Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Antivenin Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Antivenin Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Antivenin Sales by Country (2024-2034) & (K Vials)
Table 104. Middle East and Africa Antivenin Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Antivenin Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Antivenin Sales Market Share in Value by Country (2024-2034)
Table 107. CSL Company Information
Table 108. CSL Introduction and Business Overview
Table 109. CSL Antivenin Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2024-2024)
Table 110. CSL Antivenin Product
Table 111. CSL Recent Development
Table 112. Merck Company Information
Table 113. Merck Introduction and Business Overview
Table 114. Merck Antivenin Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2024-2024)
Table 115. Merck Antivenin Product
Table 116. Merck Recent Development
Table 117. BTG Company Information
Table 118. BTG Introduction and Business Overview
Table 119. BTG Antivenin Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2024-2024)
Table 120. BTG Antivenin Product
Table 121. BTG Recent Development
Table 122. Pfizer Company Information
Table 123. Pfizer Introduction and Business Overview
Table 124. Pfizer Antivenin Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2024-2024)
Table 125. Pfizer Antivenin Product
Table 126. Pfizer Recent Development
Table 127. Haffkine Bio-Pharmaceutical Company Information
Table 128. Haffkine Bio-Pharmaceutical Introduction and Business Overview
Table 129. Haffkine Bio-Pharmaceutical Antivenin Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2024-2024)
Table 130. Haffkine Bio-Pharmaceutical Antivenin Product
Table 131. Haffkine Bio-Pharmaceutical Recent Development
Table 132. Rare Disease Therapeutics Company Information
Table 133. Rare Disease Therapeutics Introduction and Business Overview
Table 134. Rare Disease Therapeutics Antivenin Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2024-2024)
Table 135. Rare Disease Therapeutics Antivenin Product
Table 136. Rare Disease Therapeutics Recent Development
Table 137. Flynn Pharma Company Information
Table 138. Flynn Pharma Introduction and Business Overview
Table 139. Flynn Pharma Antivenin Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2024-2024)
Table 140. Flynn Pharma Antivenin Product
Table 141. Flynn Pharma Recent Development
Table 142. Vins Bioproducts Company Information
Table 143. Vins Bioproducts Introduction and Business Overview
Table 144. Vins Bioproducts Antivenin Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2024-2024)
Table 145. Vins Bioproducts Antivenin Product
Table 146. Vins Bioproducts Recent Development
Table 147. Bharat Serums and Vaccines Company Information
Table 148. Bharat Serums and Vaccines Introduction and Business Overview
Table 149. Bharat Serums and Vaccines Antivenin Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2024-2024)
Table 150. Bharat Serums and Vaccines Antivenin Product
Table 151. Bharat Serums and Vaccines Recent Development
Table 152. Serum Biotech Company Information
Table 153. Serum Biotech Introduction and Business Overview
Table 154. Serum Biotech Antivenin Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2024-2024)
Table 155. Serum Biotech Antivenin Product
Table 156. Serum Biotech Recent Development
Table 157. MicroPharm Company Information
Table 158. MicroPharm Introduction and Business Overview
Table 159. MicroPharm Antivenin Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2024-2024)
Table 160. MicroPharm Antivenin Product
Table 161. MicroPharm Recent Development
Table 162. CSL Company Information
Table 163. CSL Introduction and Business Overview
Table 164. CSL Antivenin Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2024-2024)
Table 165. CSL Antivenin Product
Table 166. CSL Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Antivenin Market Trends
Table 170. Antivenin Market Drivers
Table 171. Antivenin Market Challenges
Table 172. Antivenin Market Restraints
Table 173. Antivenin Distributors List
Table 174. Antivenin Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Antivenin Product Picture
Figure 2. Global Antivenin Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Antivenin Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Antivenin Sales Status and Outlook (2024-2034) & (K Vials)
Figure 5. Product Picture of Polyvalent
Figure 6. Global Polyvalent Sales YoY Growth (2024-2034) & (K Vials)
Figure 7. Product Picture of Monovalent
Figure 8. Global Monovalent Sales YoY Growth (2024-2034) & (K Vials)
Figure 9. Global Antivenin Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Antivenin Sales Market Share by Type in 2022 & 2034
Figure 11. North America Antivenin Sales Market Share in Volume by Type in 2022
Figure 12. North America Antivenin Sales Market Share in Value by Type in 2022
Figure 13. Europe Antivenin Sales Market Share in Volume by Type in 2022
Figure 14. Europe Antivenin Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Antivenin Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Antivenin Sales Market Share in Value by Type in 2022
Figure 17. Latin America Antivenin Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Antivenin Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Antivenin Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Antivenin Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Antivenin Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Antivenin Revenue in 2022
Figure 23. Antivenin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospitals and Clinics
Figure 25. Global Hospitals and Clinics Sales YoY Growth (2024-2034) & (K Vials)
Figure 26. Product Picture of Non-profit Institutions
Figure 27. Global Non-profit Institutions Sales YoY Growth (2024-2034) & (K Vials)
Figure 28. Global Antivenin Sales by Application (2024-2034) & (US$ Million)
Figure 29. Global Antivenin Sales Market Share by Application in 2022 & 2034
Figure 30. North America Antivenin Sales Market Share in Volume by Application in 2022
Figure 31. North America Antivenin Sales Market Share in Value by Application in 2022
Figure 32. Europe Antivenin Sales Market Share in Volume by Application in 2022
Figure 33. Europe Antivenin Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Antivenin Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Antivenin Sales Market Share in Value by Application in 2022
Figure 36. Latin America Antivenin Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Antivenin Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Antivenin Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Antivenin Manufacturing Cost Structure
Figure 41. Antivenin Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed